Journal of Pharmaceutical Care & Health Systems

Journal of Pharmaceutical Care & Health Systems
Open Access

ISSN: 2376-0419

+44 1300 500008

Perspective Article - (2016) Volume 3, Issue 2

Pharmacy Fellowships: Challenges and Opportunities for Pharm D. Graduates

Gordon Ang, Hannah Ehrenfeld, Kathryn Garcia, Hannah Hodges, Shanon White, Mathhew Untermeyer and Fadi M Alkhateeb*
Department of Pharmacy Practice, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, MS 131, 1010 West Ave B, Kingsville, Texas 78363, USA
*Corresponding Author: Fadi M Alkhateeb, Department of Pharmacy Practice, Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, MS 131, 1010 West Ave B, Kingsville, Texas 78363, USA, Tel: +1-361-221-0608, Fax: +1-361-221-0790 Email:

Abstract

Introduction: Pharmacy fellowships are post-doctoral training programs intended to prepare pharmacy graduates for careers in research or the pharmaceutical industry. There are currently 131 pharmacy fellowship programs in the United States, but standardization, interest among students, and overall research regarding these fellowships are ambiguous at best. This literature review was conducted to describe common facilitators, challenges, contents and outcomes of fellowships, and to evaluate the group of programs as a whole. Methods: To do this, articles were identified using PubMed and a Google search engine, and were reviewed in context with the study goals. The primary search term used was “pharmacy fellowship(s).” Results: Key findings included articles describing the current state of pharmacy fellowships, the need for standardization, and how to pursue a pharmacy fellowship. A total of twelve articles were selected due to their relevance to the scope of this article. Conclusion: The current state of fellowships, their subgroups, efforts to develop and organize the group of programs, and possible careers following training are discussed. Benefits and limitations of the current fellowship system are summarized based on the current and relevant literature. Furthermore, this literature review is intended to serve as an accumulation of the current data on pharmacy fellowships to guide students interested in applying for a fellowship program

Keywords: Pharmacy fellowships; Clinical pharmacy; Global health

Introduction

Saturation of the job market in the field of pharmacy has led more and more students to seek out post-doctoral training including residencies and pharmacy fellowships in hopes of maintaining a competitive edge [1]. ASHP defines pharmacy fellowship as “a directed, highly individualized, postgraduate program designed to prepare the participant to become an independent researcher” with the ultimate goal of preparing the fellow for both independent and collaborative scientific research [2]. Despite these programs leading to non-traditional opportunities and career paths within the field of pharmacy, a study conducted by Sweet and others found only 4% of respondents applied for a fellowship, and what’s more, only half of those were accepted into a fellowship program. Furthermore, a number of respondents pursuing post-doctoral training expressed desire for more information on pharmacy fellowships throughout the course of their Pharm.D education [1]. To address students’ interest, this study aims to explore pharmacy fellowships as a path of post-doctoral training available to Pharm.D. graduates, strengths and limitations of the pharmacy fellowship system in the United States, and job outlook for fellowship graduates.

Methods

A search of PubMed and Google was conducted from March to April 2016 using the key terms “pharmacy fellowship(s)”. Results were sorted by most recent and relevance and articles were selected based on the relevance to pharmacy fellowships and post-doctoral training.

Review of Literature

Current state of fellowships

A pharmacy fellowship is defined as “a directed, highly individualized post-graduate program designed to prepare the participant to become an independent researcher” [3]. Currently, pharmacy fellowships can be offered through schools or colleges of pharmacy, healthcare institutions, or pharmaceutical companies. Programs are generally one year but can extend to two years [2]. Pharmacy fellowships are aimed at developing fellows to go into a wide variety of branches including independent research, the pharmaceutical industry, and academia. During a pharmacy fellowship program, up to 80% or more of a fellow’s time may be spent engaging in research activities, with the remaining time often being devoted to formal education [3].

In 2009, the American College of Clinical Pharmacy (ACCP) released a commentary stating that in order to appropriately train pharmacists to become clinical or translational scientists, a Ph.D. degree was recommended, as opposed to fellowship training. As expected, this recommendation caused quite a bit of debate within ACCP and within the profession. A study by McCarthy notes that the job opportunities and career pathways available to graduating pharmacists have changed greatly over the years, and this could potentially be due to a slight surplus of graduating pharmacists in recent years. Therefore, in 2013, ACCP reviewed this recommendation and reconsidered their stance [4].

Most recently, ACCP noted that the National Institute of Health (NIH) has recently put more emphasis on clinical and translational research, specifically relating to drug therapy and disease management. They continue to say that pharmacists are “uniquely positioned” to engage in both bench and clinical research [4]. However, ACCP now asks whether or not “the profession can generate enough appropriately trained pharmacists to take advantage of these opportunities” [4]. Larochelle [3] conducted a search to identify current pharmacy fellowship programs using a combination of ACPE-accredited colleges and schools of pharmacy, ACCP, and a Google search engine. From their search, 131 programs were identified. Compare this to approximately 1,600 PGY1 residency positions available, and it becomes clear that there is an insufficient number of pharmacy fellowship programs available in the United States [4].

In a large study by Burgunda, in a group of 783 graduating pharmacy students, only thirty graduates (4%) pursued fellowships. Additionally, of these thirty students, only fifteen of them (50%) were successfully placed. Several students in the study noted the need for more information on fellowships. These statistics demonstrate not only the need for the development of more pharmacy fellowship programs, but also the need for more student education about fellowship programs and the potential job opportunities prior to application. (Table 1 and 2).

Sponsoring College Sponsoring Organization Focus Length of Program
Creighton University Creighton University Medical Center Drug Information Research 2 years
Duquense University   Clinical Research Fellowship 1-2 years
Pediatrics 2 years
East Tennessee State University   Community Pharmacy 2-3 years
Howard University   Oncology 2 years
Massachusetts College of Pharmacy and Health Sciences- Brigham and Women's Hospital Outcomes Research 2 years
Massachusetts College of Pharmacy and Health Sciences- Worcester Charles River Labs Pharmaceutical Sciences 2 years
Saint Vincent Hospital Medication Safety 2 years
Midwestern University Northwestern Memorial Hospital Infectious Diseases 2 years
Northeastern University Tufts-NEMC Critical Care 2 years
Ohio State University   Pediatrics 2 years
Oregon State University/   Academic Research 2 years
Purdue University   Global Health 1 year
  Academic and Ambulatory Care 1 year
Thomas Jefferson University   Health Policy and population health, health services research, outcomes research 2 years
Touro University (CA)   Other 1-2 years
University of Arkansas for Medical Sciences College of Pharmacy   NA NA
University of Buffalo Novartis Drug Development 2-3 years
The State University of New York Clinical Pharmacokinetics Lab (CPL) Protein Therapeutics 2 years
State University of New York Upstate Medical University    
Pfizer or Novartis Drug Development 2 years
University of California- Los Angeles Terasaki Foundation Transplantation 1 year
Uinversity of Cincinnati   Transplantation 1 year
University of Colorado Kaiser Permanente- Colorado Outcomes Research 2 years
University of Connecticut Hartford Hospital Outcomes Research 2 years
University of Florida   Family Medicine 2 years
University of Houston College of Pharmacy St. Luke's Episcopal Hispital Infectious Diseases 2 years
University of Illinois at Chicago UIC Center for PharmacoeconomicResearch Infectious Diseases 2 years
  Outcomes Research 2 years
  Transplantation 2 years
University of Iowa   Ambulatory Care 2 years
  Translational Research 2 years
University of Kentucky   Infectious Diseases 2 years
University of Maryland Maryland Poison Center Toxicology 2 years
    Health Outcomes 1-2 years
University of Michigan   Nephrology 2 years
    Translational Research 2 years
University of Minnesota   NA NA
University of Missouri Kansas City   Regulatory Pharmaceuticals 2 years
University of Nebraska Nebraska Medical Center Critical Care 2 years
  Pharmacoeconomics and Outcomes Research 2 years
University of New Mexico New Mexico Poison and Drug Information Center   NA
University of New Mexico Health Sciences Center Cardiovascular Pharmacotherapy 2 years
University of North Carolina Chapel Hill   Academic Research 2 years
  Drug Development 2 years
  Infectious Diseases 2 years
  Pharmacokinetics 2 years
  Regulatory Affairs 2 years
Carolinas Poison Center Toxicology 2 years
  Nanotechnology 2-3 years
  Community Pharmacy Academia 2 years
  Educational Research 1 year
  Neocritical Care Pharmacotherapy 2 years
  Clinical Pharmacology 2 years
  Heart Failure Pharmacotherapy 2 years
  HIV Pharmacotherapy 2-3 years
  Oncology 2-3 years
University of Pittsburgh   Geriatric Pharmacotherapy 2 years
  Community Care Not specified
  Outcomes Research, Pharmacoeconomics 2 years
University of Rhode Island Providence Veterans Affairs Medical Center Infectious Diseases 2 years
  Infectious Diseases 2 years
University of the Science in Philadelphia   Clinical Research 1 year
Janssen Scientific Affairs Medical Information and Clinical Practice 2 years
McNeil Consumer Healthcare Medical Information and Regulatory Affairs 2 years
University of South Carolina Palmetto Health Richland Infectious Diseases 1 year
University of South Florida College of Pharmacy MyMatrixx Managed Care Pharmacy 1 year
Univeristy of Southern California   Pharmaceutical economics and outcomes research 2 years
University of Tennessee, Memphis     NA
University of Texas at Austin Scott and White Health Plan Managed Care Pharmacy 2 years
University of Utah   Outcomes Research and Pharmacoeconomics 2 years
  Toxicology 2 years
University of Washington Allergan Outcome Research 2 years
Bayer Policy 2 years
Virginia Commonwealth University   Other 1 year
Wayne State University   Infectious Diseases 2 years
Western University of Health Sciences   Cardiology 2 years
  Outcomes Research 2 years
  Translational Research 2 years
  Transplantation 2 years
[o] No Academic Partner Achaogen Inc. Drug Development 2 years
  Alnylam Pharmaceuticals Drug Development 2 years
  Cetero Research    
  Charleston Area Medical Center Health Education Drug Development 2 years
  National Institutes of Health Pharmacokinetics 2 years
  St. Jude's Research Hospital Clinical Pharmacy Not specified
  University Health System Consortium    
  UT M.D. Anderson Center Oncology 2 years
  VA Medical Center New York    
  Veterans Affairs Cooperative Studies Program Clinical Trials Not Specified

Table 1: Traditional Pharmacy Fellowships (Non-Industry).

Sponsoring College Sponsoring Organization Focus Length of Program
University of the Science in Philadelphia Janssen Scientific Affairs Medical Information and Clinical Practice 2 years
  McNeil Consumer Healthcare Medical Information and Regulatory Affairs 2 years
Massachusetts College of Pharmacy and Health Sciences Alexion Global Medical Information 2 years
Becton Dickinson Global Medical Affairs 2 years
  Health Economics and Outcomes Research 2 years
Biogen Regulatory Affairs 2 years
  Safety and Benefit Risk Management 2 years
Genzyme US Payer Access (MS) 2 years
  Clinical Documentation 2 years
  Global Commercial Strategy 2 years
  Global Pharmacovigilance and Epidemiology 2 years
  Medical Affairs 2 years
  Regulatory Affairs 2 years
Norvatis Early Clinical Development 2 years
Pfizer Clinical Research Pharmacy 2 years
  Clinical Supply Chain Strategy and Management 2 years
  Quality Assurance 2 years
Sunovion Medical Information 2 years
Takeda Pharmaceuticals Global Medical Information 1 year
Takeda Pharmaceuticals Global Pharmacovigilance 2 years
Northeastern University Bouve College of Health Sciences Alnylam Medical Affairs 2 years
Purdue Eli Lilly Regulatory, Drug Information 2 years
Johnson and Johnson Regulatory, Advertising and Promotion 2 years
Hook Drug Foundation Community Practice Research 2 years
Eli Lilly Medication Safety 2 years
Takeda Pharmaceuticals Global Regulatory Affairs 2 years
Rutgers Acorda Clinical Development and Medical Affairs 2 years
  Regulatory Affairs 2 years
Actelion Global Clinical Science and Epidemiology 2 years
AstraZeneca US Medical Affairs- Therapeutic Area Concentration 2 years
  US Medical Affairs- Medical Operations/Patient Safety 2 years
  Global Regulatory Affairs- Oncology 2 years
    Global Patient Safety- Oncology 2 years
Bayer Healthcare Consumer Care Global Pharmacovigilance and Product Quality and Safety 2 years
  Global Medical Affairs and Medical Development 2 years
  Global Product Development and Innovation 2 years
  Innovation and Research and Development Category Leadership 2 years
  Rx-to-OTC Swtich 2 years
  US Regulatory Affairs 2 years
Bayer Healthcare Pharmaceuticals Business development and liensing 2 years
  Clinical Operations 2 years
  Corporate and Government Customers (US Managed Markets) 2 years
  Early Pipeline Strategic Marketing 2 years
  Global Market Access/Health Economics Outcomes Research 2 years
  Global Regulatory Affairs 2 years
  Medical Communications 2 years
  Global Medical Affairs- Oncology 2 years
Bristol-Myers Squibb Regulatory Affairs 1 year
  Advertising and Promotion 1 year
  Immunoscience: Medical Information/Medical Science Liaison 2 years
  Virology Medical: Medical Inofrmation/Medical Strategy 2 years
  Cardiovascular Medical: Medical Strategy/Medical Science Liaison 2 years
  Oncology Medical: Medical Information/Clinical Trial Investigations/ Medical Sciencei Liaison 2 years
  Worldwide and US Medical Strategy: Immuno-Oncology 2 years
  Oncology Medical: Worldwide Medical Content/ US Medical Strategy 2 years
  US Medical Knowledge Management 2 years
  Health Economics and Outcomes Research 2 years
  Cardiovascular Medical: Medical Information/Worldwide Medical Content 2 years
  Policy and Advocacy 2 years
  Strategic Analytics and Business Intelligence 2 years
Catalent Applied Drug Delivery 2 years
  Celgene Corporation Global Scientific Communications 1 year
  Global Medical Information 1 year
  Global Clinical Research and Development 2 years
  Global Regulatory Affairs 2 years
  US Economics and Outcomes Research 2 years
  US Medical Affairs 2 years
  Global Market Insights 2 years
Daiichi-Sankyo Medical Affairs 2 years
  Marketing Sciences 2 years
Genentech Inc. Clinical Operations 2 years
  Clinical Science- Late Stage Development 2 years
  Medical Affairs/Medical Science Liaison 1 year
  Regulatory Affairs 2 years
  US Medical Affairs 2 years
Johnson and Johnson Global Scientific Engagement 2 years
  Promotional Compliance 2 years
Novartis Clinical Pharmacology 2 years
  Clinical Research and Development 2 years
  Drug Regulatory Affairs 2 years
  Scientific Communications/Medical Information 2 years
  Commercial Strategy/Brand Marketing 2 years
Pfizer Consumer Health Clinical Research and Development 2 years
  Global Medical Affairs 2 years
  Global Regulatory Affairs 2 years
Pfizer Inc. Global Medical Information/Global Medical Affairs 2 years
  Medical Affairs: Global Established Pharma 1 year
  Medical Affairs: Oncology 1 year
Roche Clinical Science Translational Medicine 2 years
Sanofi Aventis Clinical Documentation 2 years
  Global Pharmacovigilance and Epidemiology 2 years
  Global Regulatory Affairs 2 years
  Health Outcomes Research and Communications 2 years
    Pharmacy Account Team/Channel Development 2 years
  Strategic Marketing 2 years
  US/Global Cardiovascular Medical Affairs 2 years
  US/Global Patient Advocacy and Public Affairs 2 years
  US Medical Information Services 1 year
Sunovion Regulatory Affairs 2 years
TEVA Pharmaceuticals Regulatory Affairs: Global Branded and Generic Products 2 years
St. John's University Allergan Inc. Global Regulatory Strategy 2 years
  Clinical Development 2 years
  Regulatory Affairs: Advertising and Labeling 2 years
American Regent Medical Affairs and Pharmaceutical Marketing 2 years
  Clinical Research and Development 2 years
Daiichi Sankyo Clinical Development Oncology 2 years
  Clinical Safety 2 years
University of Illinois in Chicago TAP Pharmaceuticals    
University of North Carolina at Chapel Hill PPD Clinical Research and Drug Development 2 years
United Therapeutics Clinical Research and Drug Development 2 years
UCB- Neurology Clinical Research and Drug Development 2 years
GlaxoSmithKline Medical Affairs 2 years
United Therapeutics Medical Affairs 2 years
Quintiles Pharmacokinetics/Pharmacodynamics/Pharmacometrics 2 years
Nuventra Pharmacokinetics/Pharmacodynamics/Pharmacometrics 2 years
GlaxoSmithKline Global Regulatory Affairs 2 years
GlaxoSmithKline Pharmaceutical Outcomes Research 2 years
University of Southern California Allergan Inc. Clinical Development  
  Drug Delivery Sciences  
  Global Pharmaceutical Science  
  Infectious Diseases Pharmacology  
  Medical Affairs  
  Pharmaceutical Development  
  Pharmacokinetics and Pharmacodynamics  
University of Texas at Austin Novartis Pharmacoeconomics& Outcomes Research / Market Access (Oncology) 2 years
[o] No Academic Partner Centocor Inc.    
  Eisai Inc.    
  Eli Lilly    
  PPD (Contract research organization)    
  Procter and Ganble    
  Roche Laboratories Inc.    
  Upsher-Smith Laboratories    

Table 2: Industry Fellowships.

Sub groups of fellowships

One challenge for professional pharmacy students is the discord between fellowship programs and their categorization. A disconnect between labels for fellowships, expectations among students of fellowship focus, and a blending of the use of the terms “residency” and fellowship” have potentially caused difficulty in finding and applying for fellowships [2]. These misunderstandings of program offerings and content are a potential source of difficulty in the application process for students.

In order to remedy this difficulty, various authors have suggested methods for standardizing fellowships. For example, Larochelle [3] suggested separation of fellowship types into two categories, which they termed “traditional fellowships” and “industrial fellowships.” In this categorization scheme, traditional fellowships were those in which the ultimate goal was development of the fellow as an independent researcher and future primary investigator. These programs are traditionally highly individualized and their focus is determined by the fellow and preceptors involved. In contrast, industrial fellowships maintain a component of individually driven research, but are focused on development of a catered set of skills and experience for a focused field of pharmacy such as pharmacovigilance, regulatory affairs, or drug safety. Mueller [5] described an alternative method of fellowship categorization with four major categories: clinical practice combined clinical research and practice, industry, and combined research and graduate education. Additionally, the authors call for a greater degree of standardization among fellowships in order to guarantee similar experiences to ease entry and application by the student to fellowship programs.

While these recommendations for categorizing fellowships are not comprehensive, they do highlight the difficulties that students can face in applying and researching large numbers of varied fellowship programs, and they make recommendations for the potential standardization of fellowships into subtypes in order to ease differentiation of available programs.

ACCP optional accreditation, what is assessed

Pharmacy fellowship programs have the option to be reviewed and recognized by ACCP as a program that meets their guidelines for research and fellowship training programs. This is an optional peer review process conducted by ACCP’s Research Fellowship Program Review Committee (RFPRC). This committee reviews four areas of a fellowship program including: training program requirements, preceptor qualifications, fellowship applicant criteria, and fellowship experiences. The purpose of reviewing these areas is to ensure programs meet the minimum requirements set forth while still allowing for an individualized training program [5].

The guidelines for the fellowship training program are very broad. The training program requirements stipulate that a program should be at least two years, of which 3,000 hours should be devoted to research. Additional requirements include availability of advanced educational opportunities, appropriate facilities, qualified instructors, institutional support, and access to literature and facilities. Additionally, preceptors are evaluated and should be exemplary and qualified members in their field as evidenced by past, present, and ongoing research. Requirements for applicants include masters or doctoral degrees, clinical experience preferred, and interest in the field of research. Lastly, there are requirements of the fellowship experience including completion of one research project along with experience with various areas of the research method [5].

As previously mentioned, Larochelle reported 131 fellowship programs in the United States, and as of 2009, only 11 programs were found to have undergone the ACCP review process [3]. This ACCP review process represents an underused resource available to standardize and guide fellowship programs.

Job outlook/career path

Although there has been a shift in fellowship opportunities as a whole and a lack of standardization of programs, career opportunities following graduation from a fellowship program still highly correlate with the focus of respective fellowships. Traditionally, pharmacy fellowship graduates would most likely transition into faculty positions at schools of pharmacy, as the majority of fellowships were research based [6]. This path continues to be an opportunity for students, especially because positions in academia for clinical researchers are expected to increase [4].

However, the majority of fellowship graduates now fill positions in pharmaceutical companies or regulatory agencies, as there has been a growth of industry based fellowships [7]. Within these organizations, a pharmacist's role is distinct but generally involves research, communications, or regulatory aspects of workflow. Clinical development research is a mainstay for fellowship trained pharmacists, where an employee typically manages clinical trials, organizes protocols, and creates reports of the trials. Opportunities within economic and outcomes research also exist, and could be growing [7]. Communications itself is a broad area as a career path, as pharmacists now serve as medical science liaisons, who disseminate clinical information to entities outside of the company, and as part of medical affairs and information teams, who develop content and programs for these entities. Many fellowship graduates also work in marketing, developing effective and appropriate advertising strategies. In regulatory affairs, many pharmacists develop strategies to effectively communicate with regulatory agencies and ensure compliance with policies, or are part of the regulatory agencies and communicate with the pharmaceutical company [8].

The major organizations that provide these opportunities commonly collaborate with schools of pharmacy to create fellowships designed specifically to train pharmacists for the respective careers. Predictably, retention within a company and department after graduation from a fellowship is high (56.2% and 74.6% respectively) shown by a survey held by Melillo [7]. Consequently, a pharmacy fellowship provides the greatest opportunity to obtain an industry position post-graduation.

How to pursue

For students pursuing a pharmacy fellowship in the United States, there are few reliable or comprehensive resources available. However, one of the most helpful resources is the Industry Pharmacists Organization [9], which provides information for students interested in pursuing a pharmacy fellowship. Students can become a member for free, which allows them access to exclusive resources. Some of the highlights of the IPhO website include webinars for students that provide information about opportunities for pharmacists in the pharmaceutical industry. IPhO also has a pharmacy fellowship catalog and a guide to fellowships at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting, which help candidates decide on the exact fellowship programs he or she wants to pursue. Additionally, IPhO provides a feature called FellowMatch, allowing candidates to see which positions are open at different institutions [9] The candidate is able to upload any supplemental materials and apply to multiple industry fellowship programs through this service. While other organizations such as ACCP and American Pharmacists Association (APhA) reference pharmacy fellowships as a potential course for study on their websites, IPhO by far has the most abundant resources for students interested in pursuing fellowships. Nevertheless, not all resources are free to students on IPhO’s website, and should not be used as a sole resource for fellowship program education.

Conclusion

Pharmacy fellowships provide Pharm.D. graduates with unique opportunities to engage in clinical and translational research and prepare fellows to become individual researchers. They have been shown to reliably lead to careers focusing on research or industry, including roles in medical communications and regulatory affairs, but there are many barriers preventing students from pursuing programs. Currently, there are not enough programs to take advantage of these unique opportunities, and in many cases there is not enough education provided to student pharmacists throughout the Pharm.D. curriculum to foster interest. Additionally, the lack of clarity in categorization of fellowships presents a difficulty for students and professionals trying to understand their role in pharmacy, prompting recommendations to ease the application process and increase differentiation among the various opportunities that pharmacy fellowships provide. ACCP does offer a peer review service for fellowship programs to help standardize fellowships, although the program is currently highly underutilized. Nevertheless, there are organizations such as IPhO that serve as a resource for students. Continued study and collaboration can help organize and standardize fellowship programs to increase their visibility as an opportunity for students and develop to ensure the training provided prepares students for careers they were designed for.

References

  1. Sweet BV, Kelley KA,Janke KK, Kuba SE, Plake KS et al. (2015) Career Placement of Doctor of Pharmacy Graduates at Eight U.S. Midwestern Schools. American Journal of Pharmaceutical Education 79: 1-7.
  2. American Society of Hospital Pharmacists (1987) Definitions of pharmacy residencies and fellowships. American Journal of Hospital Pharmacy 44: 1142-1144.
  3. Larochelle PA, Giang DK, Silva MA, Kcomt M, Malloy MJ (2009) Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity. American Journal of Pharmaceutical Education 73: 1-9.
  4. Parker RB, Ellingrod V, DiPiro JT, Bauman JL, Blouin RA, et al. (2013) Preparing Clinical Pharmacy Scientists for Careers in Clinical/Translational Research: Can We Meet the Challenge? Pharmacotherapy 33: 337-346.
  5. Mueller EW, Bishop JR, Kanaan AO, KiserTH, Phan H, et al. (2015) Research Fellowship Programs as a Pathway for Training Independent Clinical Pharmacy Scientists. Pharmacotherapy 35: e13-e19.
  6. PowellSH, Fanikos JR, Kaul AF (1985) Positions Held By Graduates Of Postgraduate Fellowship Programs. Drug Intelligence and Clinical Pharmacy 19: 57-59.
  7. Melillo S, Gangadharan A, Johnson H, Schleck P, Steinberg M, et al. (2011) Postdoctoral pharmacy industry fellowships: A descriptive analysis of programs and postgraduate positions. American Journal of Health-System Pharmacy 69: 63-68.
  8. Institute for Pharmaceutical Industry Fellowships-Ernest Mario School of Pharmacy (2016) Career Opportunities For Pharmacists And The Pharmaceutical Industry [Brochure].
Citation: Alkhateeb FM, Ang G, Ehrenfeld H, Garcia K, Hodges H, White S, Untermeyer M (2016) Pharmacy Fellowships: Challenges and Opportunities for Pharm D. Graduates. J Pharma Care Health Sys 3:163.

Copyright: © 2016 Alkhateeb FM et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top